Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Clinical trial NCT00053131 · COMPLETED
Trial details
- NCT number
- NCT00053131
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-01-01
- Primary completion
- 2004-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.